CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...
Phase 2
Birmingham, Alabama, United States and 2 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Birmingham, Alabama, United States and 230 other locations
tumors....
Phase 1
Birmingham, Alabama, United States and 7 other locations
can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...
Phase 1, Phase 2
Birmingham, Alabama, United States and 52 other locations
and clinical antitumor activity of XB002 administered IV q3w alone and in combination with nivolumab to subjects with advanced solid tumors....
Phase 1
Birmingham, Alabama, United States and 94 other locations
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial...
Phase 3
Birmingham, Alabama, United States and 206 other locations
to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...
Phase 1
Birmingham, Alabama, United States and 44 other locations
The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...
Phase 1, Phase 2
Birmingham, Alabama, United States and 49 other locations
include tumors in the colon or rectum, the uterus and the cervix (lower part of the uterus), the bladder, and the biliary tract (includes g...
Phase 2
Birmingham, Alabama, United States and 50 other locations
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like you...
Phase 1
Birmingham, Alabama, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal